ACRX Acelrx Pharmaceuticals Inc

AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company. The Company is engaged in the development and commercialization of therapies for the treatment of acute pain.

$1.37
As of 06/24/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  02/11/2011
Outstanding shares:  119,102,999
Average volume:  1,789,443
Market cap:   $158,406,989
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    00444T100
ISIN:        US00444T1007
Sedol:      B5STJG2
Valuation   (See tab for details)
PE ratio:   -4.81
PB ratio:   -5.79
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy